Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1997 1
1999 1
2000 1
2004 2
2005 2
2007 3
2008 1
2009 2
2010 3
2011 2
2012 2
2013 4
2014 2
2015 3
2016 5
2017 10
2018 7
2019 14
2020 18
2021 20
2022 20
2023 14
2024 36
2025 22

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Improving health equity through clinical innovation.
Alfred M, Tully KP. Alfred M, et al. Among authors: tully kp. BMJ Qual Saf. 2022 Jul 26:bmjqs-2021-014540. doi: 10.1136/bmjqs-2021-014540. Online ahead of print. BMJ Qual Saf. 2022. PMID: 35882539 No abstract available.
Delta-like ligand 3-targeted radioimmunotherapy for neuroendocrine prostate cancer.
Korsen JA, Gutierrez JA, Tully KM, Carter LM, Samuels ZV, Khitrov S, Poirier JT, Rudin CM, Chen Y, Morris MJ, Bodei L, Pillarsetty N, Lewis JS. Korsen JA, et al. Among authors: tully km. Proc Natl Acad Sci U S A. 2022 Jul 5;119(27):e2203820119. doi: 10.1073/pnas.2203820119. Epub 2022 Jun 27. Proc Natl Acad Sci U S A. 2022. PMID: 35759660 Free PMC article.
[Early cystectomy-patient selection and technique].
Roghmann F, Mayr R, Tully K, Engelmann S, Burger M, Noldus J. Roghmann F, et al. Among authors: tully k. Urologe A. 2021 Nov;60(11):1424-1431. doi: 10.1007/s00120-021-01682-7. Epub 2021 Oct 15. Urologe A. 2021. PMID: 34652475 Review. German.
Defining statistical cure in patients with T1 high-grade non-muscle-invasive bladder carcinoma treated with BCG immunotherapy.
Subiela JD, de la Parra I, Taborda J, Medina AA, Pichler R, Krajewski W, Ojeda CM, Mardomingo AF, Durán PDO, Pérez EL, González-Padilla DA, Aumatell J, Mori K, Scilipoti P, Longoni M, de Angelis M, Caño-Velasco J, Puentedura AL, Pujol LP, Contieri R, Gallioli A, Tukiendorf A, D'Andrea D, Teoh JY, Afferi L, Del Giudice F, Marcq G, Albisinni S, Soria F, Mertens LS, Laukhtina E, Tully K, Mari A, Guerrero-Ramos F, Alvarez-Maestro M, Martín CC, Melendres FA, Buisan O, López-González JA, Dominguez-Escrig JL, Aranda J, Elena JLR, Basile G, Santos VGD, Moschini M, Pradere B, Acosta EA, Palacio FL, Puig AC, Gajate P, Saiz A, Gontero P, Revilla FJB; From Young Academic Urologist: Urothelial Carcinoma Working Group. Subiela JD, et al. Among authors: tully k. BJU Int. 2025 Aug 29. doi: 10.1111/bju.16913. Online ahead of print. BJU Int. 2025. PMID: 40883258
Adjuvant Immune Checkpoint Inhibitors for Muscle-Invasive Urothelial Carcinoma: An Updated Systematic Review, Meta-analysis, and Network Meta-analysis.
Yanagisawa T, Mori K, Matsukawa A, Kawada T, Katayama S, Laukhtina E, Rajwa P, Quhal F, Pradere B, Fukuokaya W, Iwatani K, Afferi L, Marcq G, Mertens LS, Gallioli A, Tully KH, Caño-Velasco J, Subiela JD, Abu-Ghanem Y, Grobet-Jeandin E, Del Giudice F, Pichler R, Teoh JY, Moschini M, Krajewski W, Miki J, Shariat SF, Kimura T; European Association of Urology–Young Academic Urologists Urothelial Carcinoma Working Group (EAU-YAU). Yanagisawa T, et al. Among authors: tully kh. Target Oncol. 2025 Jan;20(1):57-69. doi: 10.1007/s11523-024-01114-4. Epub 2024 Nov 13. Target Oncol. 2025. PMID: 39535690
Feedbacks Regulating the Salinization of Coastal Landscapes.
Kirwan ML, Michael HA, Gedan KB, Tully KL, Fagherazzi S, McDowell NG, Molino GD, Pratt D, Reay WG, Stotts S. Kirwan ML, et al. Among authors: tully kl. Ann Rev Mar Sci. 2025 Jan;17(1):461-484. doi: 10.1146/annurev-marine-070924-031447. Epub 2024 Nov 25. Ann Rev Mar Sci. 2025. PMID: 39259980 Free article. Review.
Long-term outcomes of active surveillance for Grade Group 1 prostate cancer and the impact of the use of MRI on overtreatment.
de Vos II, Marenghi C, Badenchini F, Boevé ER, Lozano-Uruñuela F, Graefen M, Rannikko AS, Staerman F, Sugimoto M, Kato T, Somford DM, Frydenberg M, Bangma CH, Remmers S, Roobol MJ; Prostate Cancer Research International: Active Surveillance (PRIAS) consortium. de Vos II, et al. BJU Int. 2025 Aug;136(2):245-253. doi: 10.1111/bju.16727. Epub 2025 Apr 14. BJU Int. 2025. PMID: 40223578 Free PMC article.
162 results